Molecular Sieve Desiccants Market Size, Share, & Industry Analysis Report: By Form (Beads, Pellets, and Powder), By End Use, and By Region – Market Forecast, 2025–2034

The molecular sieve desiccants market size is expected to reach USD 6,326.85 million by 2034, according to a new study by Polaris Market Research. The report “Molecular Sieve Desiccants Market Size, Share, & Industry Analysis Report: By Form (Beads, Pellets, and Powder), By End Use, and By Region – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The molecular sieve desiccants market encompasses highly porous crystalline materials, primarily zeolites engineered to selectively adsorb water and other molecules based on size exclusion and polarity. These desiccants are critical in environments requiring stringent moisture control and chemical stability, particularly in high-performance applications across industrial gas processing, pharmaceuticals, electronics, and packaging sectors. Demand is escalating due to increased utilization of specialty chemicals, where moisture-sensitive formulations require ultra-dry handling and storage. The adoption of advanced process systems in the petrochemicals and natural gas industries has intensified the deployment of molecular sieves for dehydration, purification, and separation. Industry trends reveal a growing emphasis on engineered pore structures and multi-functional sieves, offering enhanced adsorption capacity, regeneration efficiency, and selectivity for a broader range of volatile compounds. Adoption is further supported by the integration of these desiccants in precision-driven applications such as biotechnology, cleanrooms, and microelectronics, where even trace moisture levels can compromise performance.

Market participants are investing in scalable, low-dust, and thermally stable formulations that cater to evolving application requirements while aligning with environmental and safety regulations. Opportunities are emerging in energy-efficient regeneration technologies and hybrid adsorption systems, enabling sustainability and operational cost reduction. Strategic collaborations between material science firms and end-user industries are driving innovation in formulation-specific sieve designs, optimized for both static and dynamic systems. Overall, the market trajectory reflects a shift toward customized, high-efficiency desiccants that align with advanced manufacturing and quality assurance protocols, reinforcing the indispensable role of molecular sieve technology in modern industrial operations.

Molecular Sieve Desiccants Market Report Highlights

By form, in 2024, the beads segment captured the largest share, driven by their superior surface area-to-volume ratio and consistent adsorption performance in dynamic systems.

Based on end use, in 2024, the oil & gas segment dominated the market, fueled by the critical need for efficient gas dehydration and contaminant removal across upstream and midstream operations.

In 2024, the Asia Pacific molecular sieve desiccants market held the largest share due to robust industrial manufacturing across sectors such as chemicals, pharmaceuticals, and petrochemicals

The North America molecular sieve desiccants market is projected to register the highest CAGR during the forecast period due to accelerating advancements in gas separation technologies and moisture-sensitive packaging solutions.

A few global key players include Axens, BASF SE, Bear River Zeolite Company, Caledon Laboratories Limited, CECA (Arkema), Clariant Produkte (Schweiz AG), Honeywell UOP, Interra Global Corporation, KNT Group, and Zeochem AG.

Polaris Market Research has segmented the molecular sieve desiccants market report on the basis of form, end use, and region:

By Form Outlook (Revenue, USD Million, 2020–2034)

Beads

Pellets

Powder

By End Use Outlook (Revenue, USD Million, 2020–2034)

Pharmaceutical

Electronics

Oil & Gas

Food & Beverage

Others

By Regional Outlook (Revenue, USD Million, 2020–2034)

North America

US

Canada

Mexico

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Brazil

Argentina

Rest of Latin America


1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Source
3.2.1. Primary Source
3.2.2. Secondary Source
4. Global Molecular Diagnostics For Sexually Transmitted Diseases Market Insights
4.1. Molecular Diagnostics For Sexually Transmitted Diseases Market – Market Snapshot
4.2. Molecular Diagnostics For Sexually Transmitted Diseases Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Increasing Incidence of Sexually Transmitted Diseases
4.2.1.2. Technological Advancements in Diagnostic Tools
4.2.2. Restraints and Challenges
4.2.2.1. High Cost of Diagnostic Tests and Equipment
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Molecular Diagnostics For Sexually Transmitted Diseases Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product
5.1. Key Findings
5.2. Introduction
5.2.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
5.3. Instruments & Services
5.3.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Instruments & Services, by Region, 2020–2034 (USD Billion)
5.4. Consumables
5.4.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Consumables, by Region, 2020–2034 (USD Billion)
5.5. Software
5.5.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Software, by Region, 2020–2034 (USD Billion)
6. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application
6.1. Key Findings
6.2. Introduction
6.2.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
6.3. CT/NG testing
6.3.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by CT/NG testing, by Region, 2020–2034 (USD Billion)
6.4. Syphilis testing
6.4.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Syphilis testing, by Region, 2020–2034 (USD Billion)
6.5. Gonorrhea testing
6.5.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Gonorrhea testing, by Region, 2020–2034 (USD Billion)
6.6. HSV testing
6.6.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by HSV testing, by Region, 2020–2034 (USD Billion)
6.7. HPV testing
6.7.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by HPV testing, by Region, 2020–2034 (USD Billion)
6.8. HIV testing
6.8.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by HIV testing, by Region, 2020–2034 (USD Billion)
6.9. Trichomonas
6.9.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Trichomonas, by Region, 2020–2034 (USD Billion)
6.10. Ureaplasma + Mycoplasma
6.10.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Ureaplasma + Mycoplasma, by Region, 2020–2034 (USD Billion)
6.11. Others
6.11.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Others, by Region, 2020–2034 (USD Billion)
7. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology
7.1. Key Findings
7.2. Introduction
7.2.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
7.3. Laboratory Testing
7.3.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Laboratory Testing, by Region, 2020–2034 (USD Billion)
7.3.2. Commercial/Private Labs
7.3.3. Public Health Labs
7.4. PoC testing
7.4.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by PoC testing, by Region, 2020–2034 (USD Billion)
8. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Geography
8.1. Key Findings
8.2. Introduction
8.2.1. Molecular Diagnostics For Sexually Transmitted Diseases Market Assessment, By Geography, 2020–2034 (USD Billion)
8.3. Molecular Diagnostics For Sexually Transmitted Diseases Market – North America
8.3.1. North America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.3.2. North America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.3.3. North America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
8.3.4. Molecular Diagnostics For Sexually Transmitted Diseases Market – U.S.
8.3.4.1. U.S.: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.3.4.2. U.S.: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.3.4.3. U.S.: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
8.3.5. Molecular Diagnostics For Sexually Transmitted Diseases Market – Canada
8.3.5.1. Canada: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.3.5.2. Canada: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.3.5.3. Canada: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
8.4. Molecular Diagnostics For Sexually Transmitted Diseases Market – Europe
8.4.1. Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.4.2. Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.4.3. Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
8.4.4. Molecular Diagnostics For Sexually Transmitted Diseases Market – UK
8.4.4.1. UK: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.4.4.2. UK: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.4.4.3. UK: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
8.4.5. Molecular Diagnostics For Sexually Transmitted Diseases Market – France
8.4.5.1. France: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.4.5.2. France: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.4.5.3. France: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
8.4.6. Molecular Diagnostics For Sexually Transmitted Diseases Market – Germany
8.4.6.1. Germany: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.4.6.2. Germany: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.4.6.3. Germany: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
8.4.7. Molecular Diagnostics For Sexually Transmitted Diseases Market – Italy
8.4.7.1. Italy: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.4.7.2. Italy: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.4.7.3. Italy: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
8.4.8. Molecular Diagnostics For Sexually Transmitted Diseases Market – Spain
8.4.8.1. Spain: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.4.8.2. Spain: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.4.8.3. Spain: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
8.4.9. Molecular Diagnostics For Sexually Transmitted Diseases Market – Netherlands
8.4.9.1. Netherlands: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.4.9.2. Netherlands: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.4.9.3. Netherlands: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
8.4.10. Molecular Diagnostics For Sexually Transmitted Diseases Market – Russia
8.4.10.1. Russia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.4.10.2. Russia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.4.10.3. Russia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
8.4.11. Molecular Diagnostics For Sexually Transmitted Diseases Market – Rest of Europe
8.4.11.1. Rest of Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.4.11.2. Rest of Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.4.11.3. Rest of Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
8.5. Molecular Diagnostics For Sexually Transmitted Diseases Market – Asia Pacific
8.5.1. Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.5.2. Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.5.3. Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
8.5.4. Molecular Diagnostics For Sexually Transmitted Diseases Market – China
8.5.4.1. China: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.5.4.2. China: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.5.4.3. China: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
8.5.5. Molecular Diagnostics For Sexually Transmitted Diseases Market – India
8.5.5.1. India: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.5.5.2. India: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.5.5.3. India: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
8.5.6. Molecular Diagnostics For Sexually Transmitted Diseases Market – Malaysia
8.5.6.1. Malaysia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.5.6.2. Malaysia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.5.6.3. Malaysia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
8.5.7. Molecular Diagnostics For Sexually Transmitted Diseases Market – Japan
8.5.7.1. Japan: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.5.7.2. Japan: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.5.7.3. Japan: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
8.5.8. Molecular Diagnostics For Sexually Transmitted Diseases Market – Indonesia
8.5.8.1. Indonesia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.5.8.2. Indonesia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.5.8.3. Indonesia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
8.5.9. Molecular Diagnostics For Sexually Transmitted Diseases Market – South Korea
8.5.9.1. South Korea: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.5.9.2. South Korea: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.5.9.3. South Korea: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
8.5.10. Molecular Diagnostics For Sexually Transmitted Diseases Market – Australia
8.5.10.1. Australia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.5.10.2. Australia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.5.10.3. Australia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
8.5.11. Molecular Diagnostics For Sexually Transmitted Diseases Market – Rest of Asia Pacific
8.5.11.1. Rest of Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.5.11.2. Rest of Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.5.11.3. Rest of Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
8.6. Molecular Diagnostics For Sexually Transmitted Diseases Market – Middle East & Africa
8.6.1. Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.6.2. Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.6.3. Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
8.6.4. Molecular Diagnostics For Sexually Transmitted Diseases Market – Saudi Arabia
8.6.4.1. Saudi Arabia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.6.4.2. Saudi Arabia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.6.4.3. Saudi Arabia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
8.6.5. Molecular Diagnostics For Sexually Transmitted Diseases Market – UAE
8.6.5.1. UAE: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.6.5.2. UAE: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.6.5.3. UAE: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
8.6.6. Molecular Diagnostics For Sexually Transmitted Diseases Market – Israel
8.6.6.1. Israel: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.6.6.2. Israel: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.6.6.3. Israel: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
8.6.7. Molecular Diagnostics For Sexually Transmitted Diseases Market – South Africa
8.6.7.1. South Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.6.7.2. South Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.6.7.3. South Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
8.6.8. Molecular Diagnostics For Sexually Transmitted Diseases Market – Rest of Middle East & Africa
8.6.8.1. Rest of Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.6.8.2. Rest of Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.6.8.3. Rest of Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
8.7. Molecular Diagnostics For Sexually Transmitted Diseases Market – Latin America
8.7.1. Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.7.2. Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.7.3. Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
8.7.4. Molecular Diagnostics For Sexually Transmitted Diseases Market – Mexico
8.7.4.1. Mexico: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.7.4.2. Mexico: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.7.4.3. Mexico: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
8.7.5. Molecular Diagnostics For Sexually Transmitted Diseases Market – Brazil
8.7.5.1. Brazil: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.7.5.2. Brazil: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.7.5.3. Brazil: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
8.7.6. Molecular Diagnostics For Sexually Transmitted Diseases Market – Argentina
8.7.6.1. Argentina: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.7.6.2. Argentina: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.7.6.3. Argentina: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
8.7.7. Molecular Diagnostics For Sexually Transmitted Diseases Market – Rest of Latin America
8.7.7.1. Rest of Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020–2034 (USD Billion)
8.7.7.2. Rest of Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020–2034 (USD Billion)
8.7.7.3. Rest of Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020–2034 (USD Billion)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. Abbott Laboratories
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Recent Development
10.2. Becton, Dickinson and Company (BD)
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Recent Development
10.3. bioMérieux SA
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Recent Development
10.4. DiaSorin S.p. A.
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Recent Development
10.5. F. Hoffmann-La Roche AG (Roche Diagnostics)
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Recent Development
10.6. Hologic Inc.
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Recent Development
10.7. QIAGEN N.V.
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Recent Development
10.8. QuidelOrtho Corporation
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Recent Development
10.9. Seegene Inc.
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Recent Development
10.10. Siemens Healthineers AG
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Recent Development
10.11. Thermo Fisher Scientific Inc.
10.11.1. Company Overview
10.11.2. Financial Performance
10.11.3. Product Benchmarking
10.11.4. Recent Development

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings